TWD 37.6
(-5.41%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 501.05 Million TWD | 102.78% |
2022 | 247.08 Million TWD | -15.68% |
2021 | 293.03 Million TWD | 23.67% |
2020 | 236.95 Million TWD | 32.91% |
2019 | 178.28 Million TWD | 187.55% |
2018 | 62 Million TWD | -12.68% |
2017 | 71 Million TWD | -11.25% |
2016 | 80 Million TWD | 0.0% |
2015 | - TWD | 0.0% |
2014 | - TWD | -100.0% |
2013 | 1.26 Million TWD | -19.58% |
2012 | 1.57 Million TWD | 0.0% |
2011 | - TWD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 505.06 Million TWD | 0.8% |
2024 Q2 | 504.16 Million TWD | -0.18% |
2023 Q1 | 225.11 Million TWD | -8.89% |
2023 FY | 501.05 Million TWD | 102.78% |
2023 Q2 | 216.77 Million TWD | -3.7% |
2023 Q3 | 507.54 Million TWD | 134.13% |
2023 Q4 | 501.05 Million TWD | -1.28% |
2022 FY | 247.08 Million TWD | -15.68% |
2022 Q4 | 247.08 Million TWD | -1.73% |
2022 Q3 | 251.43 Million TWD | -5.63% |
2022 Q2 | 266.44 Million TWD | -4.36% |
2022 Q1 | 278.6 Million TWD | -4.92% |
2021 Q2 | 273.87 Million TWD | 6.39% |
2021 Q1 | 257.43 Million TWD | 8.64% |
2021 Q4 | 293.03 Million TWD | -4.81% |
2021 Q3 | 307.82 Million TWD | 12.4% |
2021 FY | 293.03 Million TWD | 23.67% |
2020 Q1 | 180.46 Million TWD | 1.22% |
2020 Q2 | 158.02 Million TWD | -12.43% |
2020 Q3 | 144.98 Million TWD | -8.25% |
2020 Q4 | 236.95 Million TWD | 63.43% |
2020 FY | 236.95 Million TWD | 32.91% |
2019 Q2 | 177.87 Million TWD | -2.2% |
2019 FY | 178.28 Million TWD | 187.55% |
2019 Q4 | 178.28 Million TWD | 5.59% |
2019 Q3 | 168.85 Million TWD | -5.08% |
2019 Q1 | 181.88 Million TWD | 193.36% |
2018 FY | 62 Million TWD | -12.68% |
2018 Q1 | 68.75 Million TWD | -3.17% |
2018 Q4 | 62 Million TWD | -3.5% |
2018 Q3 | 64.25 Million TWD | -3.38% |
2018 Q2 | 66.5 Million TWD | -3.27% |
2017 FY | 71 Million TWD | -11.25% |
2017 Q4 | 71 Million TWD | -3.07% |
2017 Q3 | 73.25 Million TWD | -2.98% |
2017 Q2 | 75.5 Million TWD | -2.89% |
2017 Q1 | 77.75 Million TWD | -2.81% |
2016 Q2 | - TWD | 0.0% |
2016 Q4 | 80 Million TWD | 0.0% |
2016 Q3 | - TWD | 0.0% |
2016 FY | 80 Million TWD | 0.0% |
2016 Q1 | - TWD | 0.0% |
2015 Q3 | - TWD | -100.0% |
2015 Q4 | - TWD | 0.0% |
2015 Q2 | 2 Million TWD | -7.11% |
2015 Q1 | 2.15 Million TWD | 0.0% |
2015 FY | - TWD | 0.0% |
2014 Q1 | - TWD | -100.0% |
2014 FY | - TWD | -100.0% |
2014 Q4 | - TWD | -100.0% |
2014 Q3 | 137 Thousand TWD | -59.94% |
2014 Q2 | 342 Thousand TWD | 0.0% |
2013 Q2 | 2.7 Million TWD | 0.0% |
2013 FY | 1.26 Million TWD | -19.58% |
2013 Q1 | - TWD | -100.0% |
2013 Q4 | 1.26 Million TWD | 0.0% |
2012 Q3 | - TWD | 0.0% |
2012 Q4 | 1.57 Million TWD | 0.0% |
2012 FY | 1.57 Million TWD | 0.0% |
2011 FY | - TWD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | -24.407% |
Level Biotechnology Inc. | 13.5 Million TWD | -3610.954% |
TaiMed Biologics Inc. | 750.85 Million TWD | 33.269% |
GlycoNex Incorporation | 900 Thousand TWD | -55572.556% |
GeneReach Biotechnology Corp. | 257.03 Million TWD | -94.933% |
Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | -56.515% |
Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | -76.669% |
Visgeneer Inc. | 158.6 Million TWD | -215.91% |
Neith Corporation | 3.54 Million TWD | -14050.042% |
Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | -3873.458% |
Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 74.623% |
TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | -42688.471% |
Enimmune corporation | 45.73 Million TWD | -995.581% |
TaiRx, Inc. | 12.28 Million TWD | -3978.244% |
CHO Pharma, Inc. | - TWD | -Infinity% |
BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | -760.827% |
Sunny Pharmtech Inc. | 391.42 Million TWD | -28.007% |
Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | -8395.303% |
Feng Chi Biotech Corp. | 10.79 Million TWD | -4540.239% |
Lukas Biomedical Inc. | 82.55 Million TWD | -506.932% |
RBC Bioscience Corporation | 487.36 Million TWD | -2.809% |
NaviFUS Corp. | 32.69 Million TWD | -1432.6% |
BRIM Biotechnology, Inc. | 3.59 Million TWD | -13849.137% |
Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -93032.528% |
Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | -3385.586% |
Sagittarius Life Science Corp | 13.32 Million TWD | -3660.812% |
Bio Preventive Medicine Corp. | 113.44 Million TWD | -341.663% |
Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -57492.299% |
BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | -3727.169% |
G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | -9125.796% |
Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | -1747.472% |
Lin BioScience, Inc. | 42.87 Million TWD | -1068.691% |
Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | -36129.429% |
AP Biosciences Inc | 82.07 Million TWD | -510.452% |
Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | -187.816% |
Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 26.506% |
EirGenix Inc. | 465.16 Million TWD | -7.715% |
Pharmosa Biopharm Inc. | 144.36 Million TWD | -247.064% |
Mycenax Biotech Inc. | 726.27 Million TWD | 31.011% |
SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | -23601.656% |
Eusol Biotech Co.,Ltd. | 4.35 Million TWD | -11407.878% |
NeoCore Technology Co., Ltd. | 96.89 Million TWD | -417.131% |
VBI | - TWD | -Infinity% |
BiOptic Inc. | 93.19 Million TWD | -437.622% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | -20.152% |
Sinew Pharma Inc. | 6.46 Million TWD | -7651.439% |
Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | -155.465% |
Medigen Biotechnology Corp. | 2.91 Billion TWD | 82.792% |
3D Global Biotech Inc. | 10.37 Million TWD | -4727.565% |
Intech Biopharm Corporation | 1.43 Billion TWD | 65.085% |
Oneness Biotech Co., Ltd. | 397.95 Million TWD | -25.909% |
TWi Biotechnology, Inc. | 7.97 Million TWD | -6185.949% |
TCI GENE Inc. | 6.79 Million TWD | -7273.848% |
MegaPro Biomedical Co., Ltd | 8.31 Million TWD | -5923.72% |
Senhwa Biosciences, Inc. | 9.6 Million TWD | -5118.758% |
Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | -86.527% |
NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | -4590.629% |
PharmaEngine, Inc. | 14.8 Million TWD | -3283.436% |
Savior Lifetec Corporation | 270.37 Million TWD | -85.317% |
TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | -570.87% |
Meribank Biotech Co., Ltd | 34.03 Million TWD | -1371.997% |
Acepodia, Inc. | 273.81 Million TWD | -82.992% |
Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | -2349.179% |